ArticleJournal of hepatology2024

Which risk model can better predict hepatocellular carcinoma in hepatitis B patients with an antiviral treatment duration of over 1 year?

Ming-Cheng Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.